|
1. Pinsky PF, Kramer BS, Reding D, Buys S. Reported family history of cancer in the prostate, lung, colorectal, and ovarian cancer screening trial. Am J Epidemiol. 2003 May 1;157(9):792-9.
2. Eddy DM. Screening for colorectal cancer. Ann Intern Med. 1990 Sep 1;113(5):373-84.
3. Fung T, Hu FB, Fuchs C, et al. Major dietary patterns and the risk of colorectal cancer in women. Arch Intern Med. 2003 Feb 10;163(3):309-14.
4. Steinberg SM, Barkin JS, Kaplan RS, Stablein DM. Prognostic indicators of colon tumors. The Gastrointestinal Tumor Study Group experience. Cancer. 1986 May 1;57(9):1866-70.
5. Chao A, Connell CJ, Cokkinides V, et al. Underuse of screening sigmoidoscopy and colonoscopy in a large cohort of US adults. Am J Public Health. 2004 Oct;94(10):1775- 81.
6. Waddell WR, Ganser GF, Cerise EJ, Loughry RW. Sulindac for polyposis of the colon. Am J Surg. 1989 Jan;157(1):175-9.
7. Wang D, Wang H, Shi Q, et al. Prostaglandin E(2) promotes colorectal adenoma growth via transactivation of the nuclear peroxisome proliferator-activated receptor delta. Cancer Cell. 2004 Sep;6(3):285-95.
8. Vane JR. Inhibition of prostaglandin synthesis as a mechanism of action for aspirin-like drugs. Nat New Biol. 1971 Jun 23;231(25):232-5.
9. Giovannucci E, Egan KM, Hunter DJ, et al. Aspirin and the risk of colorectal cancer in women. N Engl J Med. 1995 Sep 7;333(10):609-14.
10. Boyer J, Liu RH. Apple phytochemicals and their health benefits. Nutr J. 2004 May 12;3(1):5.
11. Peters U, Sinha R, Chatterjee N, et al. Dietary fibre and colorectal adenoma in a colorectal cancer early detection programme. Lancet. 2003 May 3;361(9368):1491-5.
12. Bhat KP, Pezzuto JM. Cancer chemopreventive activity of resveratrol. Ann NY Acad Sci. 2002 May;957:210-29.
13. Chauhan DP. Chemotherapeutic potential of curcumin for colorectal cancer. Curr Pharm Des. 2002;8(19):1695-706.
14. Kim YI. Role of folate in colon cancer development and progression. J Nutr. 2003 Nov;133(11 Suppl 1):3731S-9S.
15. Duthie SJ, Narayanan S, Brand GM, Grant G. DNA stability and genomic methylation status in colonocytes isolated from methyl-donor-deficient rats. Eur J Nutr. 2000 Jun;39(3):106-11.
16. Available at: http://www.prohealthlibrary.com/library/print.cfm?ID=150&t=Health. Accessed December 7, 2004.
17. Giovannucci E, Stampfer MJ, Colditz GA, et al. Multivitamin use, folate, and colon cancer in women in the Nurses’ Health Study. Ann Intern Med. 1998 Oct 1;129(7):517-24.
18. Harnack L, Jacobs DR, Jr., Nicodemus K, et al. Relationship of folate, vitamin B-6, vitamin B-12, and methionine intake to incidence of colorectal cancers. Nutr Cancer. 2002;43(2):152-8.
19. Newmark HL, Heaney RP, Lachance PA. Should calcium and vitamin D be added to the current enrichment program for cereal- grain products? Am J Clin Nutr. 2004 Aug;80(2):264-70.
20. Bond JH. Polyp guideline: diagnosis, treatment, and surveillance for patients with colorectal polyps. Practice Parameters Committee of the American College of Gastroenterology. Am J Gastroenterol. 2000 Nov;95(11):3053-63.
21. Wu K, Willett WC, Fuchs CS, Colditz GA, Giovannucci EL. Calcium intake and risk of colon cancer in women and men. J Natl Can cer Inst. 2002 Mar 20;94(6):437-46.
22. Wallace K, Baron JA, Cole BF, et al. Effect of calcium supplementation on the risk of large bowel polyps. J Natl Cancer Inst. 2004 Jun 16;96(12):921-5.
23. Holt PR. Dairy foods and prevention of colon cancer: human studies. J Am Coll Nutr. 1999 Oct;18(5 Suppl):379S-91S.
24. Grau MV, Baron JA, Sandler RS, et al. Vita- min D, calcium supplementation, and colorectal adenomas: results of a randomized trial. J Natl Cancer Inst. 2003 Dec 3;95(23):1765-71.
25. Fuchs CS, Giovannucci EL, Colditz GA, et al. Dietary fiber and the risk of colorectal cancer and adenoma in women. N Engl J Med. 1999 Jan 21;340(3):169-76.
26. Lieberman DA, Prindiville S, Weiss DG, Willett W. Risk factors for advanced colonic neoplasia and hyperplastic polyps in asymptomatic individuals. JAMA. 2003 Dec 10;290(22):2959-67.
27. McCullough ML, Robertson AS, Chao A, et al. A prospective study of whole grains, fruits, vegetables and colon cancer risk. Cancer Causes Control. 2003 Dec;14(10):959-70.
28. Ferguson LR, Philpott M, Karunasinghe N. Dietary cancer and prevention using antimutagens. Toxicology. 2004 May 20;198(1- 3):147-59.
29. Combs GF, Jr., Gray WP. Chemopreventive agents: selenium. Pharmacol Ther. 1998 Sep;79(3):179-92.
30. Al Taie OH, Seufert J, Karvar S, et al. Selenium supplementation enhances low selenium levels and stimulates glutathione peroxidase activity in peripheral blood and distal colon mucosa in past and present carriers of colon adenomas. Nutr Cancer. 2003;46(2):125-30.
31. Borek C. Dietary antioxidants and human cancer. Integr Cancer Ther. 2004 Dec;3(4):333-41.
32. Simopoulos AP. The traditional diet of Greece and cancer. Eur J Cancer Prev. 2004 Jun;13(3):219-30.
33. Murray NR, Weems C, Chen L, et al. Protein kinase C betaII and TGFbetaRII in omega-3 fatty acid-mediated inhibition of colon car- cinogenesis. J Cell Biol. 2002 Jun 10;157(6):915-20.
34. Koo MW, Cho CH. Pharmacological effects of green tea on the gastrointestinal system. Eur J Pharmacol. 2004 Oct 1;500(1-3):177- 85.
35. Aneja R, Hake PW, Burroughs TJ, et al. Epi-gallocatechin, a green tea polyphenol, attenuates myocardial ischemia reperfusion injury in rats. Mol Med. 2004 Jan;10(1-6):55-62.
36. Chen D, Daniel KG, Kuhn DJ, et al. Green tea and tea polyphenols in cancer prevention. Front Biosci. 2004 Sep 1;9:2618-31.
37. Ji BT, Chow WH, Hsing AW, et al. Green tea consumption and the risk of pancreatic and colorectal cancers. Int J Cancer. 1997 Jan 27;70(3):255-8.
38. Hong J, Smith TJ, Ho CT, August DA, Yang CS. Effects of purified green and black tea polyphenols on cyclooxygenase- and lipoxy- genase-dependent metabolism of arachidonic acid in human colon mucosa and colon tumor tissues. Biochem Pharmacol. 2001 Nov 1;62(9):1175-83.
39. Martin AR, Villegas I, La Casa C, de la Lastra CA. Resveratrol, a polyphenol found in grapes, suppresses oxidative damage and stimulates apoptosis during early colonic inflammation in rats. Biochem Pharmacol. 2004 Apr 1;67(7):1399-410.
40. Polasa K, Naidu AN, Ravindranath I, Krish naswamy K. Inhibition of B(a)P induced strand breaks in presence of curcumin. Mutat Res. 2004 Feb 14;557(2):203-13.
41. Takada Y, Bhardwaj A, Potdar P, Aggarwal BB. Nonsteroidal anti-inflammatory agents differ in their ability to suppress NF-kappaB activation, inhibition of expression of cyclooxygenase-2 and cyclin D1, and abrogation of tumor cell proliferation. Oncogene. 2004 Oct 18.
42. Casimiro C. Etiopathogenic factors in colorectal cancer. Nutritional and life-style aspects. 2. Nutr Hosp. 2002 May;17(3):128- 38.
43. Rex DK, Johnson DA, Lieberman DA, Burt RW, Sonnenberg A. Colorectal cancer prevention 2000: screening recommendations of the American College of Gastroenterology. American College of Gastroenterology. Am J Gastroenterol. 2000 Apr;95(4):868-77.
44. Wenzel U, Herzog A, Kuntz S, Daniel H. Protein expression profiling identifies molecular targets of quercetin as a major dietary flavonoid in human colon cancer cells. Proteomics. 2004 Jul;4(7):2160-74. |